| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2800 | 3-O-Benzyl-naltrindole |
2800.0001: 1 mg per vial
Please inquire for customized filling and bulk quantities.
|
|
Precursor for N1′([11C]Methyl)-naltrindole
Highly selective antagonist for δ opioid receptors |
||
| Molar Mass: 504.62 | ||
| C33H32N2O3 | ||
| [161532-22-5] | ||
| Yellowish solid packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazol-8a(9H)-ol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-1-(phenylmethoxy-), (8R-(4bS*, 8a, 8a.beta,14b.beta)]; |
||
|
Synonymes: 3-BNTI; 17-(Cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3-benzyloxy-14-hydroxy-6,7,2′,3′-indolomorphinan |
||
|
Literature: 1. Madar I. et al. Imaging of δ- and μ-Opioid Receptors in Temporal Lobe Epilepsy by Positron Emission Tomography. Annals of Neurology 1997, 41, 358-367. |
||
| 2. Lever J.R. et al. Synthesis of N1′-([11C]methyl)naltrindole ([11C]MeNTI): A radioligand for positron emission tomographic studies of δ opioid receptors. J. Labelled Compd. Radiopharm. 1995, 36, 137-145. | ||
| date of product catalogue issue: 21 Decmber 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1